Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion type Assertion NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_head.
- NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion description "[E-cadherin expression, however, was significantly higher among intestinal cancers from the two countries: 56.3 per cent of cells from intestinal or mixed cancers from Japan (n = 32) expressed E-cadherin compared with 22.2 per cent of American specimens (n = 12; P = 0.008).-c-erbB2 was expressed on a higher proportion of malignant cells from American specimens (30% vs 22%; P = 0.20).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_provenance.
- NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion evidence source_evidence_literature NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_provenance.
- NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion SIO_000772 16676859 NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_provenance.
- NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion wasDerivedFrom befree-2016 NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_provenance.
- NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_assertion wasGeneratedBy ECO_0000203 NP548347.RASKggyc5zY_YzFPdlOOGMQBovO_UgZk55Y5kBytfuL5I130_provenance.